Bi Asset Management Fondsmaeglerselskab A Axsome Therapeutics, Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 05, 2020	SELL	$49.87 - $98.69 $792,484 - $1.57 Million	-15,891 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$41.2 - $101.31 $654,709 - $1.61 Million	15,891 New	15,891 $935,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.